Skip to main content
Fig. 8 | Journal of Experimental & Clinical Cancer Research

Fig. 8

From: New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

Fig. 8

G9a inhibition reduces PHGDH expression in a mouse model of CCA. a Diagram showing the experimental model and the treatments applied (n = 6 mice per group). b Phgdh mRNA levels in the liver of wild type mice, JnkΔhepa mice, JnkΔhepa mice treated with CCl4 and diethylnitrosamine (DEN) (JnkΔhepa + CCl4 + DEN mice) and JnkΔhepa + CCl4 + DEN mice treated with CM-272 as indicated. **p < 0.01. c Immunohistochemical detection of PHGDH in liver tissue sections from mice treated as described in b. Representative images are shown. Created with BioRender.com

Back to article page